Probiotic Species in the Management of Periodontal Diseases: An Overview
- PMID: 35402306
- PMCID: PMC8990095
- DOI: 10.3389/fcimb.2022.806463
Probiotic Species in the Management of Periodontal Diseases: An Overview
Abstract
Periodontal diseases are one of the most common chronic inflammatory diseases of the oral cavity, which are initiated and sustained by pathogenic plaque biofilms. Central to modern periodontology is the idea that dysbiosis of periodontal microecology and disorder of host inflammatory response gives rise to degradation of periodontal tissues together, which eventually leads to tooth loss, seriously affecting the life quality of patients. Probiotics were originally used to treat intestinal diseases, while in recent years, extensive studies have been exploring the utilization of probiotics in oral disease treatment and oral healthcare. Probiotic bacteria derived from the genera Lactobacillus, Bifidobacterium, Streptococcus, and Weissella are found to play an effective role in the prevention and treatment of periodontal diseases via regulating periodontal microbiota or host immune responses. Here, we review the research status of periodontal health-promoting probiotic species and their regulatory effects. The current issues on the effectiveness and safety of probiotics in the management of periodontal diseases are also discussed at last. Taken together, the use of probiotics is a promising approach to prevent and treat periodontal diseases. Nevertheless, their practical use for periodontal health needs further research and exploration.
Keywords: immunoregulation; microecological balance; periodontal disease; periodontopathogen; probiotic.
Copyright © 2022 Zhang, Ding and Guo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Adam E., Jindal M., Seney S., Summers K., Hamilton D., Hatibović-Kofman S., et al. . (2011). Streptococcus Salivarius K12 and M18 Probiotics Reduce Periodontal Pathogen-Induced Inflammation. In: IADR General Session 2011. (San Diego, California, United States: )
-
- Agrawal A., Houghton L. A., Morris J., Reilly B., Guyonnet D., Goupil Feuillerat N., et al. . (2009). Clinical Trial: The Effects of a Fermented Milk Product Containing Bifidobacterium Lactis DN-173 010 on Abdominal Distension and Gastrointestinal Transit in Irritable Bowel Syndrome With Constipation. Aliment. Pharmacol. Ther. 29, 104–114. doi: 10.1111/j.1365-2036.2008.03853.x - DOI - PubMed
-
- Alanzi A., Honkala S., Honkala E., Varghese A., Tolvanen M., Söderling E. (2018). Effect of Lactobacillus Rhamnosus and Bifidobacterium Lactis on Gingival Health, Dental Plaque, and Periodontopathogens in Adolescents: A Randomised Placebo-Controlled Clinical Trial. Benef Microbes 9, 593–602. doi: 10.3920/BM2017.0139 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Molecular Biology Databases